New Century Pharmaceuticals is categorized under Medical Research in Huntsville, AL and active since 1996.
New Century Pharmaceuticals was established in 1996, and today employs 1 to 4, earning Unknown per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 5417110 by the NAICS.
If you are seeking more information, feel free to contact Daniel Carter, Owner at the company’s single location by writing to 895 Martin Road Sw, Huntsville, Alabama AL 35824 or by phoning (256) 461-0024. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | New Century Pharmaceuticals |
| Contact Person: | Daniel Carter, Owner |
| Address: | 895 Martin Road Sw, Huntsville, Alabama 35824 |
| Phone Number: | (256) 461-0024 |
| Website Address: | newcenturypharm.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 5417110 |
| Share This Business: |
New Century Pharmaceuticals was started in 1996 to provide professional Medical Research under the SIC code 8733 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Daniel Carter, Owner for inquiries that concern New Century Pharmaceuticals by calling the company number (256) 461-0024, as your correspondence is most welcome. Additionally, the physical location of the single location of New Century Pharmaceuticals can be found at the coordinates 34.65023,-86.74948 as well as the street address 895 Martin Road Sw in Huntsville, Alabama 35824.
For its online presence, you may visit New Century Pharmaceuticals’s website at newcenturypharm.com and engage with its social media outlets through on Twitter and on Facebook.